| __timestamp | Alnylam Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 580006000 |
| Thursday, January 1, 2015 | 41097000 | 676585000 |
| Friday, January 1, 2016 | 47159000 | 778966000 |
| Sunday, January 1, 2017 | 76545000 | 671251000 |
| Monday, January 1, 2018 | 73106000 | 463508000 |
| Tuesday, January 1, 2019 | 194688000 | 445724000 |
| Wednesday, January 1, 2020 | 414801000 | 399725000 |
| Friday, January 1, 2021 | 704143000 | 296656000 |
| Saturday, January 1, 2022 | 868601000 | 293122000 |
| Sunday, January 1, 2023 | 1517886000 | 268323000 |
| Monday, January 1, 2024 | 1924873000 | 304979000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, Alnylam Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have showcased contrasting trajectories in their gross profit trends over the past decade. From 2014 to 2023, Alnylam Pharmaceuticals experienced a remarkable growth, with its gross profit surging by over 2,900%, peaking at approximately $1.52 billion in 2023. This growth reflects Alnylam's strategic advancements and successful product launches.
Conversely, Taro Pharmaceutical Industries Ltd. faced a decline, with its gross profit decreasing by about 54% from its 2016 peak of $778 million to $268 million in 2023. This decline may be attributed to increased competition and market challenges.
The data for 2024 remains incomplete, leaving room for speculation on future trends. As the pharmaceutical industry continues to evolve, these companies' financial performances will be pivotal in shaping their market positions.
Key Insights on Gross Profit: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Merck & Co., Inc. or Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: AstraZeneca PLC and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Trends Compared: Zoetis Inc. vs Taro Pharmaceutical Industries Ltd.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. Trends
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown